Dr. Scott Michael Dembiec, MD

Dr. Dembiec practices at Mercy Hospital South in Saint Louis, Missouri, part of Mercy.

Dr. Dembiec's NPI, 1619178159, was assigned on May 31, 2007. Dr. Dembiec holds Missouri license 2006019871.

Dr. Dembiec's primary practice is Mercy Hospital South, at 10010 Kennerly Road, Saint Louis, MO 63128 in St. Louis County. The practice phone is (314) 525-1000.

Dr. Dembiec's primary practice is Mercy Hospital South in Saint Louis, Missouri, part of Mercy. Dr. Dembiec is also affiliated with Mercy Hospital St. Louis. The medical group on file is Generation Clinical Partners. Dmand AI also links Dr. Dembiec to 4 more hospitals, 10 medical groups, 5 hospices, 4 group practices and clinics and 4 skilled nursing facilities, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dembiec practices, 19 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dembiec's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dembiec is licensed in Missouri.

CMS data shows 2,871 Medicare services from Dr. Dembiec across 12 procedure codes in 2024, for 709 Medicare patients. Medicare paid $231,353 for them.

CMS counts 709 Medicare patients who saw Dr. Dembiec in 2024. The largest group is 75 to 84, with 240 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dembiec's median patient age at 79, with 61% women.

In 2024, Dr. Dembiec wrote 6,737 Medicare Part D claims for 488 patients. 86% of them were for generic drugs. CMS names the drug for 5,925 of them, across 131 drugs with 11 or more claims each, at $375,852 in total drug cost. In 2023, CMS named 510 claims across 21 drugs.

Dr. Dembiec accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Dembiec from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $559.